Recent investigations postulate a participation of the interferon regulatory factor-1 (IRF-1) in the development of myelodysplasia (MDS) and in the pathogenesis of autoimmune manifestations (AIMs) in patients with this disease. The aim of this prospective study was to compare the IRF-1 immunoexpress
Mo1831 The Role of Interferon Regulatory Factor (IRF)-1 and IRF-2 in the Progression of Human Pancreatic Cancer
β Scribed by Sakai, Toshitaka; Mashima, Hirosato; Yamada, Yumi; Goto, Takashi; Ohnishi, Hirohide
- Book ID
- 122298805
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 119 KB
- Volume
- 144
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract IRFβ1 and IRFβ2 expression was determined by realβtime PCR in 138 ovarian cancer samples and 30 healthy ovarian biopsies and was correlated with the expression of other relevant immunologic parameters and common clinicopathologic variables. Regulation of IRFβ1 and IRFβ2 was evaluated by
IRF2 is a transcription factor, possessing oncogenic potential, responsible for both the repression of growth-inhibiting genes (interferon) and the activation of cell cycle-regulated genes (histone H4). Surprisingly little is known about the post-translational modification of this factor. In this st